TNF and systemic lupus erythematosus: During hospitalization, intravenous dexamethasone was started in all patients (11 of 11 patients), in addition to treating 4/11 patients with tocilizumab for worsening respiratory conditions: 2 patients with rheumatoid arthritis, who were previously treated by golimumab (anti-tumor necrosis factor) and 2 patients with lupus, one of whom was treated with rituximab and the other with azathioprine and hydroxychloroquine.